Avicanna Inc., a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, has announced that it will host its 5th medical symposium on Cannabinoid-based Medicine on June 6th, 2025.
The Toronto-based Symposium, From Emerging Evidence to Clinical Practice, is open to healthcare practitioners and researchers and will include various speakers covering a variety of topics-ranging from emerging evidence to current clinical practices on the practical application of cannabinoid-based medicine. The speakers include Canadian and international key opinion leaders, clinicians, and scientists from leading academic, research, and clinical organizations.
Featured Speakers and Topics:
| Speaker | Topic |
| Dr. Carrie Cuttler Washington State University |
Getting by Without the High: Examining the Therapeutic Potential of Cannabigerol |
| Dr. Jason McDougall Dalhousie University |
A Role for Cannabinoids in the Management of Arthritis |
| Carlo De Angelis Sunnybrook Health Sciences Centre |
Tales From the Front Lines: Unique Uses of Medical Cannabis – Patient Cases |
| Dr. Daniel Bear Humber College |
Building Better Drugs Education for People Who Know a Lot About (Certain) Drugs – Considerations for Medical Cannabis |
| Dr. Zachary Walsh University of British Colombia |
Cannabis and Problematic Substance Use: New Finding on Substitution and Harm Reduction from High-Risk Populations |
| Dr. Kelly Dunn John Hopkins School of Medicine |
Human Laboratory Evidence of Opioid-cannabinoid Interactions and the Role of Opioids |
| Dr. Hance Clarke University Health Network |
Canadian Medical Cannabis Clinical Trials Network |
| Dr. Jennifer Baumbusch University of British Columbia |
Cannabis Use among Older Adults: Current Research and Implications for Clinical Practice |
| Dr. Evan Lewis North Toronto Neurology |
Cannabis-Based Therapies for Epilepsy: What’s New & What’s Next |
“Building on the success of last year’s event, this year’s Symposium seeks to enhance our collective understanding of cannabinoid-based medicines arising from the latest developments on an international perspective. We are pleased to host this symposium and provide a platform for these important exchanges, fostering collaboration and education of the medical community on medical cannabis” stated Dr. Karolina Urban, Executive Vice President of Medical Affairs at Avicanna.
In addition to keynote presentations and panel discussions, Avicanna invites abstract submissions for a dedicated poster presentation session. Researchers, clinicians and health care practitioners are encouraged to submit abstracts showcasing their latest findings and developments in the field of cannabinoid-based medicine. This poster session will serve as a valuable platform for knowledge exchange and will foster meaningful dialogue among attendees.
To register for the symposium and submit abstract for poster presentation:
Health care practitioners and researchers, may apply for registration and submit abstracts for poster presentation at: www.avicanna.com/symposium
